We found that IL1R1+ Treg cells were more effective than their IL1R1− counterparts at suppressing proliferation of CD8+ (Fig. 4a) and CD4+ responder T (Tresp) cells isolated from tumours as well as from peripheral blood (Extended Data Fig. 7a). Here, CD8A is linked to neoplasm.